AOCSII : 2017 Onwards
| Name | Affiliation | Role |
| A/Prof Paul James | Peter MacCallum Cancer Centre | A/Prof James will assist with developing relationships with the Peter Mac Familial Cancer Clinic (FCC) and associated national FCC network. He will also be involved with determining the clinical significance of any research findings. |
| Ms Mary-Anne Young | Garvan Institute of Medical Research | MaryAnne Young will use her many years of experience to help develop relationships with Familial Cancer Clinic network across Australia. She will also be involved with determining the clinical significance of any research findings. |
| A/Prof Orla McNally | The Royal Women’s Hospital, VIC | A/Prof McNally is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof McNally will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Linda Mileshkin | Peter MacCallum Cancer Centre | A/Prof Mileshkin is a collaborating Medical Oncologist and has been involved in AOCS for several years. A/Prof Mileshkin will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Dr George Au-Yeung | Peter MacCallum Cancer Centre | Dr AuYeung has been involved in AOCS for several years and will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Dr Simon Hyde | Mercy Hospital for Women, VIC | Dr Hyde is head of Gynaecological Oncology at the Mercy Hospital for Women. Dr Hyde is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. Dr Hyde will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Peter Grant | Mercy Hospital for Women, VIC | A/Prof Grant is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Grant will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Rob Rome | Epworth Freemasons Medical Centre | A/Prof Rome is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Rome will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Prof Neville Hacker | Royal Hospital for Women, NSW | Prof Hacker is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Hacker will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Prof Michael Friedlander | Prince of Wales Hospital | Prof Friedlander is a collaborating Medical Oncologist and has been involved in AOCS since it began in 2002. Prof Friedlander will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Dr Greg Gard | Royal North Shore Hospital | Dr Gard is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. Dr Gard will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Prof Paul Harnett | Westmead Hospital | Prof Harnett is a collaborating Medical Oncologist and has been involved in AOCS since the study began in 2002. Prof Harnett will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Alison Brand | Westmead Hospital | A/Prof Brand is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Brand will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Dr Bo Gao | Blacktown Hospital | Dr Gao is a collaborating Medical Oncologist and has previously been involved in AOCS analysis. Dr Gao will be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Russell Land | Greenslopes Specialist Gynaecology | A/Prof Land is a collaborating Gynaecological Oncologist and will be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Prof Andreas Obermair | Royal Brisbane & Women’s Hospital, QLD | Prof Obermair is a collaborating Gynaecological Oncologist and has been involved in AOCS for many years. Prof Obermair will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof James Nicklin | The Wesley Hospital | A/Prof Nicklin is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Nicklin will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Lewis Perrin | Mater Hospital Brisbane | A/Prof Perrin is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Perrin will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| A/Prof Penny Blomfield | Royal Hobart Hospital | A/Prof Blomfield is a collaborating Gynaecological Oncologist and has been involved in AOCS since the study began in 2002. A/Prof Blomfield will continue to be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
| Dr Michael Bunting | Royal Hobart Hospital | Dr Bunting is a collaborating Gynaecological Oncologist. Dr Bunting will be responsible for identifying eligible cases for the study and assist in facilitating access to their clinical information. |
AOCSI : 2001-2017
A full list of all AOCS I members is available here.
Social Media